Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe

• Julian P. Halcox ,

  * E-mail: J.P.J.Halcox@swansea.ac.uk

  Affiliation Institute of Life Sciences 2, Swansea University College of Medicine, Swansea, United Kingdom

  ⨯
• Florence Tubach,

  Affiliations INSERM CIC-EC 1425 and Epidemiology and Clinical Research Department, Assistance Publique—Hôpitaux de Paris, Hôpital Bichat, Paris, France, Univ Paris Diderot, Sorbonne Paris Cité, UMR 1123, Paris, France

  ⨯
• Esther Lopez-Garcia,

  Affiliation Department of Preventative Medicine and Public Health, Universidad Autónoma de Madrid IdiPaz and CIBERESP, Madrid, Spain

  ⨯
• Guy De Backer,

  Affiliation Department of Public Health, University of Ghent, Ghent, Belgium

  ⨯
• Claudio Borghi,

  Affiliation Department of Internal Medicine, Ageing and Clinical Nephrology, University of Bologna, Bologna, Italy

  ⨯
• Jean Dallongeville,

  Affiliation INSERM U 744, Institut Pasteur de Lille, Université Lille-Nord de France, Lille, France

  ⨯
• Eliseo Guallar,

  Affiliations Departments of Epidemiology and Medicine and Welch Center of Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research, Madrid, Spain

  ⨯
• Jesús Medina,

  Affiliation Observational Research Centre, Global Medical Affairs, AstraZeneca Farmacéutica Spain, Madrid, Spain

  ⨯
• Joep Perk,

  Affiliation School of Health and Caring Sciences, Linnaeus University, Kalmar, Sweden

  ⨯
• Ogün Sazova,

  Affiliation AstraZeneca Global Medical Affairs, London, United Kingdom

  ⨯
• Stephen Sweet,

  Affiliation Research Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, United Kingdom

  ⨯
• Carine Roy,

  Affiliation INSERM CIC-EC 1425 and Epidemiology and Clinical Research Department, Assistance Publique—Hôpitaux de Paris, Hôpital Bichat, Paris, France

  ⨯
• José R. Banegas,

  Affiliation Department of Preventative Medicine and Public Health, Universidad Autónoma de Madrid IdiPaz and CIBERESP, Madrid, Spain

  ⨯
• Fernando Rodriguez-Artalejo

  Affiliation Department of Preventative Medicine and Public Health, Universidad Autónoma de Madrid IdiPaz and CIBERESP, Madrid, Spain

  ⨯